Market cap
$192 Mln
Revenue (TTM)
$71 Mln
P/E Ratio
--
P/B Ratio
15.7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 15.23 | 15.92 | 20.83 | 10.35 | 8.73 |
| EBIT | 25.11 | 39.14 | 2.67 | 14.49 | 4.13 |
| Net Profit | 19.44 | 28.00 | -11.44 | 13.49 | 1.39 |
| EPS | 20.47 | 37.18 | 7.88 | 16.82 | 7.57 |
| Book Value | -- | -- | 54.44 | -31.05 | -24.53 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -29.04 | -47.23 | -19.35 | -23.41 | -23.13 |
| Net Margin
| -- | -55.57 | -26.61 | -- | -- |
| Return on equity
| -104.78 | -86.22 | -127.58 | -147.85 | -93.78 |
| Return on Capital
| -43.11 | -41.72 | -- | -52.57 | -38.43 |
| Return on Assets
| -33.90 | -34.70 | -28.15 | -38.85 | -29.74 |
| Debt to Equity (x)
| -- | -- | 1.83 | 1.47 | 2.43 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
--
|
-52.57
|
-38.43
|
-38.34
|
-49.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-127.58
Lower than Peers by 135.54
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
-127.58
|
-147.85
|
-93.78
|
-72.72
|
-74.39
|
|
Peer Median
|
7.96
|
--
|
--
|
--
|
--
|
ROA
-28.15
Lower than Peers by 30.29
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
-28.15
|
-38.85
|
-29.74
|
-33.09
|
-45.20
|
|
Peer Median
|
2.14
|
--
|
--
|
--
|
--
|
EBIT Margin
-19.35
Lower than Peers by 26.40
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
-19.35
|
-23.41
|
-23.13
|
-40.57
|
-99.25
|
|
Peer Median
|
7.06
|
--
|
--
|
--
|
--
|
Net Margin
-26.61
Lower than Peers by 29.76
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
-26.61
|
-29.97
|
-27.17
|
-45.08
|
-104.00
|
|
Peer Median
|
3.16
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
20.83
Higher than Peers by 11.00
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
20.83
|
0.20
|
0.06
|
0.15
|
-0.06
|
|
Peer Median
|
9.83
|
--
|
--
|
--
|
--
|
EBIT Growth
2.67
Lower than Peers by 13.53
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
2.67
|
-21.08
|
39.64
|
52.85
|
-88.02
|
|
Peer Median
|
16.21
|
--
|
--
|
--
|
--
|
Net Profit Growth
-11.44
Lower than Peers by 28.62
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
-11.44
|
-31.99
|
36.19
|
50.01
|
-76.48
|
|
Peer Median
|
17.18
|
--
|
--
|
--
|
--
|
EPS Growth
7.88
Lower than Peers by 8.22
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
7.88
|
-0.11
|
0.37
|
0.52
|
-0.74
|
|
Peer Median
|
16.10
|
--
|
--
|
--
|
--
|
Book Value Growth
-49.32
Lower than Peers by 54.44
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
-49.32
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.12
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
1.83
Higher than Peers by 1.45
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
1.83
|
1.47
|
2.43
|
1.02
|
0.83
|
|
Peer Median
|
0.38
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.13
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
0.13
|
0.17
|
0.18
|
0.05
|
0.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
3.18
Higher than Peers by 1.71
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
3.18
|
3.45
|
2.70
|
4.02
|
7.55
|
|
Peer Median
|
1.48
|
--
|
--
|
--
|
--
|
Quick Ratio
3.18
Higher than Peers by 1.80
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
3.18
|
--
|
--
|
3.78
|
7.36
|
|
Peer Median
|
1.38
|
--
|
--
|
--
|
--
|
Interest Coverage
-2.69
Lower than Peers by 7.01
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
-2.69
|
-3.61
|
-5.76
|
-9.13
|
-18.47
|
|
Peer Median
|
4.32
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
17.44
Higher than Peers by 4.32
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
17.44
|
16.30
|
14.08
|
12.47
|
13.34
|
|
Peer Median
|
13.12
|
--
|
--
|
--
|
--
|
Asset Turnover
1.06
Higher than Peers by 0.28
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
1.06
|
1.30
|
1.09
|
0.73
|
0.43
|
|
Peer Median
|
0.78
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
--
|
51.27
|
47.22
|
43.89
|
63.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
--
|
--
|
46.55
|
36.90
|
21.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
--
|
54.51
|
58.92
|
48.85
|
41.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
--
|
--
|
34.85
|
31.94
|
43.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
--
|
-6.57
|
-4.94
|
-1.50
|
-0.87
|
|
Peer Median
|
33.74
|
--
|
--
|
--
|
--
|
Price / Book Value
15.71
Higher than Peers by 12.16
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
15.71
|
7.51
|
7.82
|
1.56
|
0.97
|
|
Peer Median
|
3.54
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.16
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
-0.16
|
-9.25
|
-6.80
|
-1.16
|
-0.32
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
192
Lower than Peers by 179
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Exagen (XGN)
|
192
|
--
|
--
|
--
|
--
|
|
Peer Median
|
371
|
--
|
--
|
--
|
--
|